Impact of early anti-TNF use on clinical outcomes in Crohn’s disease: a nationwide population-based study

BACKGROUND/AIMS: The optimal timing for initiation of anti-tumor necrosis factor (TNF) therapy in Crohn’s disease (CD) is still debated. Little is known about the clinical outcomes of early versus late administration of anti-TNF agents, especially in Asian CD patients. We aimed to evaluate the impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Yoon Suk, Han, Minkyung, Park, Sohee, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487310/
https://www.ncbi.nlm.nih.gov/pubmed/32306709
http://dx.doi.org/10.3904/kjim.2020.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487310/
https://www.ncbi.nlm.nih.gov/pubmed/32306709
http://dx.doi.org/10.3904/kjim.2020.001

Ejemplares similares